Graffner C, Johnsson G, Sjögren J
Clin Pharmacol Ther. 1975 Apr;17(4):414-23. doi: 10.1002/cpt1975174414.
Pharmacokinetics of procainamide were studied in healthy volunteers after single doses intravenously and orally as conventional and slow-release tablets and after repeated oral doses to steady state. The initial distribution after intravenous administration was rapid and the overall elimination in the beta-phase corresponded to t1/2 of 2.7 hr. The mean volume of the central compartment was small and only 4 percent of V-d (beta), which was 2.3 l/kg body weight. About 65 percent was excreted unchanged after intravenous administration and about 55 percent after a single oral dose of 500 mg. The recovery of the metabolite N-acetylprocainamide was 12 percent after both routes of administration. Procainamide was completely absorbed from the gastrointestinal tract and the first-pass elimination was very limited. The rates of absorption from the tablet compositions were well correlated to the in vitro dissolution properties. Administration of slow-release tablets every 8 hr gave about the same mean plasma level at steady state as ordinary tablets given every 4 hr, and the availability was the same from both preparations. The occasional high plasma concentration peaks after ordinary tablets were not observed after the slow-release tablets. Renal clearance was about 500 ml/min, indicating an active secretion in the tubules.
在健康志愿者中研究了普鲁卡因胺的药代动力学,研究内容包括单次静脉注射和口服常规片剂及缓释片剂后的情况,以及多次口服给药至稳态后的情况。静脉给药后初始分布迅速,β相的总体消除对应半衰期为2.7小时。中央室的平均容积较小,仅为V-d(β)的4%,V-d(β)为2.3升/千克体重。静脉给药后约65%以原形排泄,单次口服500毫克后约55%以原形排泄。两种给药途径后代谢产物N-乙酰普鲁卡因胺的回收率均为12%。普鲁卡因胺可从胃肠道完全吸收,首过消除非常有限。片剂组合物的吸收速率与体外溶出特性密切相关。每8小时服用一次缓释片在稳态时的平均血浆水平与每4小时服用一次普通片大致相同,两种制剂的生物利用度相同。服用缓释片后未观察到普通片偶尔出现的高血浆浓度峰值。肾清除率约为500毫升/分钟,表明肾小管存在主动分泌。